Polymeric nanocomposite: Development, characterization, ex vivo and in vivo evaluation for ulcerative colitis

References

• Crohn’s and Colitis Foundation of America. The facts about inflammatory bowel diseases. New York, NY: CCFA, 2014. Retrieved from http://www.ccfa.org/assets/pdfs/updatedibdfactbook.pdf.
   Google Scholar
• Conrad, K.; Roggenbuck, D.; Laass, M. W. Diagnosis and classification of ulcerative colitis. Autoimmun. Rev. 2014, 13, 463–466.
   PubMed Web of Science ®Google Scholar
• Logan, I.; Bowlus, C. L. The geoepidemiology of autoimmune intestinal diseases. Autoimmun. Rev. 2010, 9, A372–A378.
   PubMed Web of Science ®Google Scholar
• Molodecky, N. A.; Soon, I. S.; Rabi, D. M.; Ghali, W. A.; Ferris, M.; Chernoff, G.; Benchimol, E. I.; Panaccione, R.; Ghosh, S.; Barkema, H. W.; Kaplan, G. G. Increasing incidence; and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012, 142, 46–54 e42, quiz e30.
   PubMed Web of Science ®Google Scholar
• Shanahan, F.; Niederlehner, A.; Carramanzana, N.; Anton, P. Sulfasalazine inhibits the binding of TNF alpha to its receptor. Immunopharmacology 1990, 20, 217–224.
   PubMed Web of Science ®Google Scholar
• Usha Rani, G.; Konreddy, A. K.; Mishra, S.; Sen, G. Synthesis and applications of polyacrylamide grafted agar as a matrix for controlled drug release of 5-ASA. Int. J. Biol. Macromol. 2014, 65C, 375–382.
   Google Scholar
• Pertuit, D.; Moulari, B.; Betz, T.; Nadarajane, A.; Neumann, D.; Ismaïli, L.; Refouvelet, B.; Pellequer, Y.; Lamprecht, A. 5-amino salicylic acid bound nanoparticles for the therapy of inflammatory bowel disease. J. Control Release 2007, 123, 211–218.
   PubMed Web of Science ®Google Scholar
• Moulari, B.; Pertuit, D.; Pellequer, Y.; Lamprecht, A. The targeting of surface modified silica nanoparticles to inflamed tissue in experimental colitis. Biomaterials 2008, 29, 4554–4560.
   PubMed Web of Science ®Google Scholar
• Grivennikov, S. I. Inflammation and colorectal cancer: colitis-associated neoplasia. Semin. Immunopathol. 2013, 35, 229–244.
   PubMed Web of Science ®Google Scholar
• Hartnett, L.; Egan, L. J. Inflammation, DNA methylation and colitis-associated cancer. Carcinogenesis 2012, 33, 723–731.
   PubMed Web of Science ®Google Scholar
• Lamprecht, A.; Schafer, U.; Lehr, C. M. Size-dependent bioadhesion of micro- and nanoparticulate carriers to the inflamed colonic mucosa. Pharm. Res. 2001, 18, 788–793.
   PubMed Web of Science ®Google Scholar
• Lamprecht, A.; Ubrich, N.; Yamamoto, H.; Schäfer, U.; Takeuchi, H.; Maincent, P.; Kawashima, Y.; Lehr, C. M. Biodegradable nanoparticles for targeted drug delivery in treatment of inflammatory bowel disease. J. Pharmacol. Exp. Ther. 2001, 299, 775–781.
   PubMed Web of Science ®Google Scholar
• Calvo, P.; Remuñan-López, C.; Vila-Jato, J. L.; Alonso, M. J. Chitosan and chitosan/ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines. Pharm. Res. 1997, 14, 1431–1436.
   PubMed Web of Science ®Google Scholar
• Banik, N.; Hussain, A.; Ramteke, A.; Sharma, H. K.; Maji, T. K. Preparation and evaluation of the effect of particle size on the properties of chitosan-montmorillonite nanoparticles loaded with isoniazid. RSC Adv. 2012, 2, 10519–10528.
   Web of Science ®Google Scholar
• Mura, C.; Manconi, M.; Valenti, D.; Manca, M. L.; Díez-Sales, O.; Loy, G.; Fadda, A. M. In vitro study of N-succinyl chitosan for targeted delivery of 5-aminosalicylic acid to colon. Carbohydr. Polym. 2011, 85, 578–583.
   Web of Science ®Google Scholar
• Yang, L.; Chu, J. S.; Fix, J. A. Colon-specific drug delivery: new approaches and in vitro/in vivo evaluation. Int. J. Pharm. 2002, 235, 1–15.
   PubMed Web of Science ®Google Scholar
• Souder, J. C.; Ellenbogen, W. Control of d-amphetamine sulfate sustained release capsule. Drug Standards 1995, 6, 77.
   Google Scholar
• Van den Mooter, G.; Samyn, C.; Kinget, R. The relation between swelling properties and enzymatic degradation of azo polymers designed for colon-specific drug delivery. Pharm. Res. 1994, 11, 1737–1741.
   PubMed Web of Science ®Google Scholar
• Tseng, C.-L.; Wang, T. W.; Dong, G. C.; Wu, S. Y. H.; Young, T. H.; Shieh, M. J.; Lou, P. J.; Lin, F. H. Development of gelatin nanoparticles with biotinylated EGF conjugation for lung cancer targeting. Biomaterials 2007, 28, 3996–4005.
   PubMed Web of Science ®Google Scholar
• Morris, G. P.; Beck, P. L.; Herridge, M. S.; Depew, W. T.; Szewczuk, M. R.; Wallace, J. L. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 1989, 96, 795–803.
   PubMed Web of Science ®Google Scholar
• Mura, C.; Nácher, A.; Merino, V.; Merino-Sanjuan, M.; Carda, C.; Ruiz, A.; Manconi, M.; Loy, G.; Fadda, A. M.; Díez-Sales, O. N-Succinyl-chitosan systems for 5-aminosalicylic acid colon delivery: In vivo study with TNBS-induced colitis model in rats. Int. J. Pharm. 2011, 416, 145–154.
   PubMed Web of Science ®Google Scholar
• Sandborn, W. J.; Hanauer, S. B. Systematic review: the pharmacokinetic profiles of oral mesalazine formulations and mesalazine pro-drugs used in the management of ulcerative colitis. Aliment. Pharmacol. Ther. 2003, 17, 29–42.
   PubMed Web of Science ®Google Scholar
• Onishi, H.; Oosegi, T.; Machida, Y. Efficacy and toxicity of Eudragit-coated chitosan–succinyl-prednisolone conjugate microspheres using rats with 2,4,6-trinitrobenzenesulfonic acid-induced colitis. Int. J. Pharm. 2008, 358, 296–302.
   PubMed Web of Science ®Google Scholar
• Oosegi, T.; Onishi, H.; Machida, Y. Gastrointestinal distribution and absorption behavior of Eudragit-coated chitosan–prednisolone conjugate microspheres in rats with TNBS-induced colitis. Int. J. Pharm. 2008, 348, 80–88.
   PubMed Web of Science ®Google Scholar
• Mladenovska, K.; Raicki, R. S.; Janevik, E. I.; Ristoski, T.; Pavlova, M. J.; Kavrakovski, Z.; Dodov, M. G.; Goracinova, K. Colon-specific delivery of 5-aminosalicylic acid from chitosan-Ca-alginate microparticles. Int. J. Pharm. 2007, 342, 124–136.
   PubMed Web of Science ®Google Scholar
• Wang, Q.; Zhang, J.; Wang, A. Preparation and characterization of a novel pH-sensitive chitosan-g-poly (acrylic acid)/attapulgite/sodium alginate composite hydrogel bead for controlled release of diclofenac sodium. Carbohydr. Polym. 2009, 78, 731–737.
   Web of Science ®Google Scholar
• Wang, X.; Du, Y.; Luo, J. Biopolymer/montmorillonite nanocomposite: preparation, drug-controlled release property and cytotoxicity. Nanotechnology 2008, 19, 065707.
   PubMed Web of Science ®Google Scholar
• Knaul, J. Z.; Hudson, S. M.; Creber, K. A. M. Improved mechanical properties of chitosan fibers. J. Appl. Poly. Sci. 1999, 72, 1721–1732.
   Web of Science ®Google Scholar
• Jain, A.; Jain, S. K.; Ganesh, N.; Barve, J.; Beg, A. M. Design and development of ligand-appended polysaccharidic nanoparticles for the delivery of oxaliplatin in colorectal cancer. Nanomedicine 2010, 6, 179–190.
   PubMed Web of Science ®Google Scholar
• Shah, S.; Pal, A.; Kaushik, V. K.; Devi, S. Preparation and characterization of venlafaxine hydrochloride-loaded chitosan nanoparticles and in vitro release of drug. J. Appl. Polym. Sci. 2009, 112, 2876–2887.
   Web of Science ®Google Scholar
• Günister, E.; Pestreli, D.; Ünlü, C. H.; Atici, O.; Güngör, N. Synthesis and characterization of chitosan-MMT biocomposite systems. Carbohydr. Polym. 2007, 67, 358–365.
   Web of Science ®Google Scholar
• Sinha, V. R.; Kumria, R. Microbially triggered drug delivery to the colon. Eur. J. Pharm Sci. 2003, 18, 3–18.
   PubMed Web of Science ®Google Scholar
• Chourasia, M. K.; Jain, S. K. Design and development of multiparticulate system for targeted drug delivery to colon. Drug Deliv. 2004, 11, 201–207.
   PubMed Web of Science ®Google Scholar
• French, D. L.; Mauger, J. W. Evaluation of the physicochemical properties and dissolution characteristics of mesalamine: relevance to controlled intestinal drug delivery. Pharm. Res. 1993, 10, 1285–1290.
   PubMed Web of Science ®Google Scholar
• Chourasia, M. K.; Jain, S. K. Polysaccharides for colon targeted drug delivery. Drug Deliv 2004, 11, 129–148.
   PubMed Web of Science ®Google Scholar
• Moghimi, S. M.; Symonds, P.; Murray, J. C.; Hunter, A. C.; Debska, G.; Szewczyk, A. A two-stage poly(ethylenimine)-mediated cytotoxicity: implications for gene transfer/therapy. Mol. Ther. 2005, 11, 990–995.
   PubMed Web of Science ®Google Scholar
• Lee, M.; Nah, J.-W.; Kwon, Y.; Koh, J. J.; Ko, K. S.; Kim, S. K. Water-soluble and low molecular weight chitosan-based plasmid DNA delivery. Pharm. Res. 2001, 18, 427–431.
   PubMed Web of Science ®Google Scholar
• Illum, L. Chitosan and its use as a pharmaceutical excipient. Pharm. Res. 1998, 15, 1326–1331.
   PubMed Web of Science ®Google Scholar
• Carreño-Gómez, B.; Duncan, R. Evaluation of the biological properties of soluble chitosan and chitosan microspheres. Int. J. Pharm. 1997, 148, 231–240.
   Web of Science ®Google Scholar
• Lin, F. H.; Chen, C. H.; Cheng, W. T.; Kuo, T. F. Modified montmorillonite as vector for gene delivery. Biomaterials 2006, 27, 3333–3338.
   PubMed Web of Science ®Google Scholar
• Lavie, S.; Stotzky, G. Adhesion of the clay minerals montmorillonite, kaolinite, and attapulgite reduces respiration of Histoplasma capsulatum. Appl. Environ. Microbiol. 1986, 51, 65–73.
   PubMed Web of Science ®Google Scholar
• Tozaki, H.; Komoike, J.; Tada, C.; Maruyama, T.; Terabe, A.; Suzuki, T.; Yamamoto, A.; Muranishi, S. Chitosan capsules for colon-specific drug delivery: improvement of insulin absorption from the rat colon. J. Pharm. Sci. 1997, 86, 1016–1021.
   PubMed Web of Science ®Google Scholar
• Rodriguez, M.; Antúnez, J. A.; Taboada, C.; Seijo, B.; Torres, D. Colon-specific delivery of budesonide from microencapsulated cellulosic cores: evaluation of the efficacy against colonic inflammation in rats. J. Pharm. Pharmacol. 2001, 53, 1207–1215.
   PubMed Web of Science ®Google Scholar
• Jiang, X. L.; Wang, H. H.; Cui, H. F. Combined diosmectite and mesalazine treatment for mild-to-moderate ulcerative colitis: a randomized, placebo-controlled study. Med. Sci. Monit. 2015, 21, 163–170.
   PubMed Web of Science ®Google Scholar
• Okayasu, I.; Hatakeyama, S.; Yamada, M.; Ohkusa, T.; Inagaki, Y.; Nakaya, R. A novel method in the induction of reliable experimental acute; and chronic ulcerative colitis in mice. Gastroenterology 1990, 98, 694–702.
   PubMed Web of Science ®Google Scholar
• Rainsford, K. D. Comparative studies of gastric ulcerogenesis by non-steroid anti-inflammatory drugs: effects of fenclofenac. Proc. R. Soc. Med. 1977, 70, 4–10.
   PubMedGoogle Scholar